Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells (original) (raw)

Susceptibility to natural killer cells and down regulation of MHC class I expression in adenovirus 12 transformed cells are regulated by different E1A domains

Maria Korom

Virus Research, 1996

View PDFchevron_right

Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity

Cornelis Melief

1983

View PDFchevron_right

Adenovirus vector delivery stimulates natural killer cell recognition

Gavin Wilkinson, Richard Stanton

Journal of General Virology, 2007

View PDFchevron_right

Modulation of cellular susceptibility to the cytotoxic/cytostatic action of tumor necrosis factor by adenovirus E1 gene expression is cell type-dependent

Bart Vanhaesebroeck

Virology, 1990

View PDFchevron_right

Human Adenoviruses: Evading Detection by Cytotoxic T Lymphocytes

Kersten Hall

Seminars in Virology, 1998

View PDFchevron_right

Autologous lymphocyte responses to adenovirus-B7-1-transduced human cancer cells

frank graham

Cancer Gene Therapy, 1999

View PDFchevron_right

Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection

Alaap Shah

Cancer research, 2002

View PDFchevron_right

Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells

Gustavo Simoes

Nature, 1983

View PDFchevron_right

The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells

Penelope Duerksen-hughes

Journal of Virology, 1991

View PDFchevron_right

The Role of Natural Killer Cells in Adenovirus-mediated p53 Gene Therapy 1

J. Michael Mathis

View PDFchevron_right

Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation

David Shalloway

Journal of virology, 1990

View PDFchevron_right

Short Communication Adenovirus vector delivery stimulates natural killer cell recognition

Gavin Wilkinson, Richard Stanton

2000

View PDFchevron_right

The role of natural killer cells in adenovirus-mediated p53 gene therapy

Stephen Pruett

Molecular cancer therapeutics, 2001

View PDFchevron_right

Extensive Cross-Reactivity of Adenovirus-Specific Cytotoxic T Cells

Linda Woodruff

Human Gene Therapy, 1998

View PDFchevron_right

Expression of a Human Coxsackie/Adenovirus Receptor Transgene Permits Adenovirus Infection of Primary Lymphocytes

Madelyn Schmidt, Mark Cabatingan

The Journal of Immunology, 2000

View PDFchevron_right

Implication of Interfering Antibody Formation and Apoptosis as Two Different Mechanisms Leading to Variable Duration of Adenovirus-Mediated Transgene Expression in Immune-Competent Mice

Mark Kay

Journal of Virology

View PDFchevron_right

The Level of Expression of Adenovirus Type 2 Transforming Genes Governs Sensitivity to Nonspecific Immune Cytolysis and Other Phenotypic Properties of Adenovirus 2-Simian Virus 40-Transformed Cell Hybrids

Arthur Levine

Molecular and Cellular Biology, 1985

View PDFchevron_right

E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens

Hans-gerhard Burgert

Proceedings of the National Academy of Sciences, 1987

View PDFchevron_right

Adenovirus proteins and MHC expression

Ingrid Martens

Advances in cancer …, 1989

View PDFchevron_right

Differential expression of LFA-3, Fas and MHC Class I on Ad5- and Ad12-transformed human cells and their susceptibility to lymphokine-activated killer (LAK) cells

Graham Bottley

Virology, 2005

View PDFchevron_right

Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis

Leonardo Mosimann Estrella

Journal of Virology, 1991

View PDFchevron_right

Duerksen-Hughes PJ, Hermiston TW, Wold WS and Gooding LRThe amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells. J. Virol. 65: 1236-1244

Penelope Duerksen-hughes

Journal of Virology

View PDFchevron_right

Adenovirus vector induced innate immune responses: Impact upon efficacy and toxicity in gene therapy and vaccine applications

Daniel Appledorn

Virus Research, 2008

View PDFchevron_right

Effect of adenovirus 2 on cellular gene activation in blood-derived monocytes and macrophages

Y. Mándi

APMIS, 1997

View PDFchevron_right

Different activities of the adenovirus types 5 and 12 E1A regions in transformation with the EJ Ha-ras oncogene

henk van kranen

Journal of Virology, 1986

View PDFchevron_right

Tumorigenicity of hamster and mouse cells transformed by adenovirus types 2 and 5 is not influenced by the level of class I major histocompatibility antigens expressed on the cells

Arthur Levine

Proceedings of the National Academy of Sciences, 1986

View PDFchevron_right

Adenovirus 2 early gene expression promotes susceptibility to effector cell lysis of hybrids formed between hamster cells transformed by adenovirus 2 and simian virus 40

Arthur Levine

Proceedings of the National Academy of Sciences, 1983

View PDFchevron_right

Adeno-Associated Virus Type 2 (AAV2) Capsid-Specific Cytotoxic T Lymphocytes Eliminate Only Vector-Transduced Cells Coexpressing the AAV2 Capsid In Vivo

Tal Kafri

Journal of Virology, 2007

View PDFchevron_right

Immunocompetent Syngeneic Cotton Rat Tumor Models for the Assessment of Replication-Competent Oncolytic Adenovirus

Brian Morrison

View PDFchevron_right

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells

William Taverner

Journal for immunotherapy of cancer, 2018

View PDFchevron_right

Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor alpha and lymphotoxin alpha

Isabella Saggio

Journal of virology, 1998

View PDFchevron_right

Impact of Preimmunization on Adenoviral Vector Expression and Toxicity In a Subcutaneous Mouse Cancer Model

Andres Hernandez-Garcia

Molecular therapy: the …, 2002

View PDFchevron_right

CD8+ T cell response mediates the therapeutic effects of oncolytic adenovirus in an immunocompetent mouse model

Yaohe Wang

Chinese Science Bulletin, 2012

View PDFchevron_right

MHC Class I Molecules on Adenovirus E1A-Expressing Tumor Cells Inhibit NK Cell Killing but Not NK Cell-Mediated Tumor Rejection

Stefanus Ryan

International …, 2001

View PDFchevron_right

Adenovirus-induced alterations in host cell gene expression prior to the onset of viral gene expression

Fredrik Granberg

Virology, 2006

View PDFchevron_right